𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia

✍ Scribed by Evan A. Stein; Leiv Ose; Kjetil Retterstøl; Serena Tonstad; Margo Schleman; Susan Harris; Philip Sager

Book ID
119287071
Publisher
Elsevier
Year
2007
Tongue
English
Weight
122 KB
Volume
1
Category
Article
ISSN
1933-2874

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Achievement of specified low-density lip
Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study)
✍ Jennifer G. Robinson; Christie M. Ballantyne; Willa Hsueh; Jeffrey Rosen; Jianxi 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 469 KB